Andy Billinton

966 citations

22 papers · 673 indexed · h-index 13

Impact in

Pharmacology top 5%
- Cannabis and Cannabinoid Research
Biological Psychiatry top 10%

Papers in ⓘ

Biological Psychiatry 2
Pharmacology 8
- Inflammatory mediators and NSAID effects 7

Co-authors: Iain P. Chessell (8 shared papers)Jon P. Hatcher (2 shared papers)Stephen J. Medhurst (4 shared papers)Julia H. White (1 shared paper)Henry J. Waldvogel (1 shared paper)Piers C. Emson (1 shared paper)Richard L. M. Faull (1 shared paper)Gerard M.P. Giblin (7 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Alzheimer s & Dementia (2 papers)Pain (2 papers)RSC Medicinal Chemistry (1 paper)The Journal of Comparative Neurology (1 paper)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Andy Billinton

21 papers receiving 659 citations

Peers

Countries citing papers authored by Andy Billinton

Since Specialization

Citations

This map shows the geographic impact of Andy Billinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Billinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Billinton more than expected).

Fields of papers citing papers by Andy Billinton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Billinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Billinton. The network helps show where Andy Billinton may publish in the future.

Co-authors

The 25 scholars most cited alongside Andy Billinton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andy Billinton Line = papers co-authored together Andy Billinton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain Pain ·Penny C. Staton, Jon P. Hatcher, Deborah J. Walker, Alastair Morrison, Ellen M. Shapland, Jane P. Hughes, Elizabeth Chong, Palwinder K. Mander, Paula J. Green, Andy Billinton, Michael Fulleylove, Hilary C. Lancaster, J. Smith, Leigh T. Bailey, Alan Wise, Andrew J. Brown, Jill Richardson, Iain P. Chessell	2008	221
2	Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain Pain ·Stephen J. Medhurst, S D Collins, Andy Billinton, Sharon Bingham, Robert Dalziel, Amanda Brass, Jennifer Roberts, Andrew D. Medhurst, Iain P. Chessell	2008	71
3	Comparative cellular distribution of GABA_A and GABA_B receptors in the human basal ganglia: Immunohistochemical colocalization of the α₁ subunit of the GABA_A receptor, and the GABA_BR1 and GABA_BR2 receptor subunits The Journal of Comparative Neurology ·Henry J. Waldvogel, Andy Billinton, Julia H. White, Piers C. Emson, Richard L. M. Faull	2004	71
4	Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy Bioorganic & Medicinal Chemistry Letters ·Adrian Hall, Andy Billinton, Susan H. Brown, Nicholas M. Clayton, A. R. Chowdhury, Gerard M.P. Giblin, Paul Goldsmith, Thomas G. Hayhow, David N. Hurst, Ian R. Kilford, Alan Naylor, Barry Passingham, Lisa Winyard	2008	66
5	Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders Journal of Medicinal Chemistry ·David Harrison, Andy Billinton, Mark G. Bock, John R. Doedens, Christopher A. Gabel, M. Katharine Holloway, Roderick A. Porter, Valérie Reader, Jane Scanlon, Kenneth Schooley, Alan P. Watt	2023	35
6	Activation of the α7-Nicotinic Acetylcholine Receptor Reverses Complete Freund Adjuvant–Induced Mechanical Hyperalgesia in the Rat Via a Central Site of Action Journal of Pain ·Stephen J. Medhurst, Jon P. Hatcher, Christopher J. Hille, Sharon Bingham, Nick M. Clayton, Andy Billinton, Iain P. Chessell	2008	34
7	Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X7 receptor Bioorganic & Medicinal Chemistry Letters ·Lee Abberley, Aude Bebius, Paul Beswick, Andy Billinton, Katharine L. Collis, David K. Dean, Elena Fonfría, Robert J. Gleave, Stephen J. Medhurst, Anton D. Michel, Andrew P. Moses, Sadhana Patel, Shilina Roman, Tiziana Scoccitti, Beverley Smith, Jon G.A. Steadman, Daryl S. Walter	2010	25
8	Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping Bioorganic & Medicinal Chemistry Letters ·Adrian Hall, Andy Billinton, Susan H. Brown, A. R. Chowdhury, Gerard M.P. Giblin, Paul Goldsmith, David N. Hurst, Alan Naylor, Sadhana Patel, Tiziana Scoccitti, Pamela J. Theobald	2008	23
9	Structure–activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor Bioorganic & Medicinal Chemistry Letters ·Paul Beswick, Andy Billinton, Laura J. Chambers, David K. Dean, Elena Fonfría, Robert J. Gleave, Stephen J. Medhurst, Anton D. Michel, Andrew P. Moses, Sadhana Patel, Shilina Roman, Sue Roomans, Stefan Senger, Alexander J. Stevens, Daryl S. Walter	2010	23
10	Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP1 receptor antagonist for the treatment of inflammatory pain Bioorganic & Medicinal Chemistry Letters ·Adrian Hall, Andy Billinton, Susan H. Brown, A. R. Chowdhury, Nicholas M. Clayton, Gerard M.P. Giblin, Mairi Gibson, Paul Goldsmith, David N. Hurst, Alan Naylor, Caroline Peet, Tiziana Scoccitti, Alexander W. Wilson, Wendy J. Winchester	2009	15
11	Biologics: the next generation of analgesic drugs? Drug Discovery Today ·Iain P. Chessell, Amanda Dudley, Andy Billinton	2012	13
12	Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Amanda C. Allan, Andy Billinton, Susan H. Brown, A. R. Chowdhury, Andrew J. Eatherton, Charlotte Fieldhouse, Gerard M.P. Giblin, Paul Goldsmith, Adrian Hall, David N. Hurst, Alan Naylor, D. Anthony Rawlings, Mairi Sime, Tiziana Scoccitti, Pamela J. Theobald	2011	13
13	Fracture-induced pain-like behaviours in a femoral fracture mouse model Osteoporosis International ·R. Magnúsdóttir, Stéphanie Gohin, Freija ter Heegde, Mark Hopkinson, I.F. McNally, Alexander A. Fisher, N. Upton, Andy Billinton, Chantal Chenu	2021	12
14	EP1 antagonists for the treatment of inflammatory pain. PubMed ·Adrian Hall, Andy Billinton, Gerard M.P. Giblin	2007	10
15	Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Adrian Hall, Andy Billinton, Alan K. Bristow, Susan H. Brown, A. R. Chowdhury, Leanne Cutler, Gerard M.P. Giblin, Paul Goldsmith, Thomas G. Hayhow, Ian R. Kilford, Alan Naylor, Barry Passingham, D. Anthony Rawlings	2008	9
16	[P1–074]: PRECLINICAL DISCOVERY AND DEVELOPMENT OF MEDI1814, A MONOCLONAL ANTIBODY SELECTIVELY TARGETING BETA‐AMYLOID 42 (Aβ42) Alzheimer s & Dementia ·Andy Billinton, Philip M. Newton, Chris J. Lloyd, Maria Groves, Fraser Welsh, Anna Bogstedt, Susanna Eketjäll, Mary McFarlane, Michael S. Perkinton, Rajesh Narwal, Keith Tan, Amanda Dudley, Tristan J. Vaughan, Iain P. Chessell	2017	9
17	Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiationin Vivo Journal of Neuroscience ·Tomáš Ondrejčák, Igor Klyubin, Neng‐Wei Hu, Tiernan T. O’Malley, Grant T. Corbett, Róisín Winters, Michael S. Perkinton, Andy Billinton, Jack Prenderville, Dominic M. Walsh, Michael J. Rowan	2023	8
18	Pharmacological Analysis of NLRP3 Inflammasome Inhibitor Sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1H-pyrazol-4-yl)({[(2S)-oxolan-2-yl]methyl})sulfamoyl]azanide in Cellular and Mouse Models of Inflammation Provides a Translational Framework ACS Pharmacology & Translational Science ·John R. Doedens, Pamela J. Smolak, MyTrang Nguyen, Heather Wescott, Christine Diamond, Ken Schooley, Andy Billinton, David Harrison, Beverly H. Koller, Alan P. Watt, Christopher A. Gabel	2024	5
19	[O2–09–02]: EVALUATION OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA‐AMYLOID 42 (Aβ42)‐SPECIFIC ANTIBODY, IN PATIENTS WITH MILD‐MODERATE ALZHEIMER'S DISEASE Alzheimer s & Dementia ·Thor Ostenfeld, Michael B. Pomfret, Andy Billinton, Iain P. Chessell, Tharani Chessell, Eva Lindqvist, Zulma Santisteban Valencia, Maria Groves, Rajesh Narwal, Manasa Tatipalli, Nancy Y. Lee, Richard Turner, Keith Tan, Amanda Dudley	2017	5
20	Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain Bioorganic & Medicinal Chemistry Letters ·Mark P. Healy, Amanda C. Allan, Kristin Bailey, Andy Billinton, Iain P. Chessell, Nicholas M. Clayton, Gerard M.P. Giblin, Melanie A. Kay, Tarik Khaznadar, Anton D. Michel, Alan Naylor, Helen S. Price, David J. Spalding, David A. Stevens, Martin E. Swarbrick, Alexander W. Wilson	2018	4

About Andy Billinton

Andy Billinton is a scholar working on Biological Psychiatry, Pharmacology, Physiology, Cellular and Molecular Neuroscience and Physiology, having authored 22 papers that have together received 673 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Neuropeptides and Animal Physiology (5 papers), Pain Mechanisms and Treatments (4 papers), Mast cells and histamine (3 papers), Asthma and respiratory diseases (3 papers), Inflammasome and immune disorders (3 papers), Macrophage Migration Inhibitory Factor (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Pharmacology (222 citations), Biological Psychiatry (32 citations), Physiology (58 citations), Cellular and Molecular Neuroscience (205 citations) and Sensory Systems (39 citations). Andy Billinton has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Iain P. Chessell, Jon P. Hatcher, Stephen J. Medhurst, Julia H. White, Henry J. Waldvogel, Piers C. Emson, Richard L. M. Faull, Gerard M.P. Giblin, Adrian Hall and Sharon Bingham. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Alzheimer s & Dementia, Pain, RSC Medicinal Chemistry and The Journal of Comparative Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact